Naproxen sodium in dysmenorrhea secondary to endometriosis.

Obstetrics and gynecology · 1985 · vol. 65(3) , pp. 379–83 · PMID:3883265 · W5416790
article OA: closed CC0 ⤵ 50 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-07

Naproxen sodium provided complete or substantial pain relief in 83% of women with endometriosis-related dysmenorrhea, significantly more than placebo, with fewer women requiring supplemental analgesics.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Twenty patients with moderate to very severe painful menstrual periods secondary to endometriosis were treated in a double-blind, four-period, crossover clinical trial with naproxen sodium and placebo. Complete or substantial pain relief was obtained in 83% of the cases of painful menstruation with naproxen sodium and in 41% with placebo (P = .008). Only 5% of the naproxen sodium-treated women needed supplemental analgesics compared with 36% of the placebo-treated women (P = .002). There was a trend towards diminished interference of dysmenorrhea with normal patient activities during naproxen sodium treatment compared with placebo (P = .069). No significant side effects occurred with either treatment. These results indicated that naproxen sodium is efficacious and safe for the treatment of menstrual distress in patients with endometriosis.

My notes (saved in your browser only)

Condition tags

mesh:D004412mesh:D004715endometriosisdysmenorrhea

MeSH descriptors

Dysmenorrhea Endometriosis Naproxen Adult Clinical Trials as Topic Double-Blind Method Dysmenorrhea Dysmenorrhea Endometriosis Female Humans Naproxen Naproxen Placebos Random Allocation

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:09:45.632124+00:00
License: CC0 · commercial use OK